Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Implications for Disease Prevention in the United States
The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.
Abstract
BACKGROUND: During the decade 1998-2007, a combination DTaP(5)-IPV/Hib vaccine was used exclusively in Canada to immunize infants and young children against diphtheria, tetanus, pertussis, polio, and invasive Haemophilus influenzae type b (Hib) disease. METHODS: Medline was used to search for publications during 1996-2008 related to the epidemiology and vaccine prevention of pertussis and invasive Hib disease in Canada. Related abstracts and presentations were reviewed, when available, and epidemiologic data since 1985 were obtained from the Public Health Agency of Canada public Web site. RESULTS: Reports of pertussis have declined substantially in preschool and school-aged children during the past decade, and cyclical peaks in disease incidence have been blunted or eliminated. In provinces and territories where Tdap(5) vaccine has been administered to 14- to 16-year-olds, marked reductions of pertussis have been documented in adolescents as well as younger age groups, possibly due to herd immunity. Incidence rates of invasive Hib disease among Canadian children <5 years declined markedly after introduction of Hib conjugate vaccines, and the disease has remained under control with exclusive use of DTaP(5)-IPV/Hib vaccine. Most cases of invasive Hib disease occur among unimmunized or only partially vaccinated children. The reduction of Hib case reports has been documented throughout Canada, including among Aboriginal children who are at high risk for this disease. CONCLUSIONS: The Canadian experience with DTaP(5)-IPV/Hib and Tdap(5) vaccines is relevant to the United States because immunization schedules, vaccination coverage rates, and epidemiologic patterns of pertussis and Hib diseases are similar in the 2 countries, and because both vaccines are licensed for use in the United States.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vaccinations have contributed to the favourable trends in the DALY rates of tetanus, meningitis, and encephalitis.31, 32, 33, 34, 35, 36, 37”
From Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2017) · cites this paper as [31]
Citations
Cites
Summary of notifiable diseases--United States, 2002.
Groseclose, S. L., Brathwaite, W. S., Hall, P. A., Connor, F. J., Sharp, P., Anderson, W. J., Fagan, R. F., Javier, A. J., Jones, G. F., Nitschke, D. A., et al. (2004) · MMWR Morbidity and Mortality Weekly Report · Cited by 1,379
Mattoo, S., & Cherry, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.326-382.2005 · Cited by 1,138
Parashar, U. (2006) · Medical Entomology and Zoology · Cited by 799
Gustafsson, L., Hallander, H. O., Olin, P., Reizenstein, E., & Storsaeter, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340602 · Cited by 737
Broder, K. R., US Department of Health and Human Services, Cortese, M. M., Iskander, J. K., Kretsinger, K., Slade, B. A., Brown, K. H., Mijalski, C. M., Tiwari, T., Weston, E. J., et al. (2006) · PsycEXTRA Dataset · doi:10.1037/e481832006-001 · Cited by 492
Kretsinger, K., Broder, K. R., Cortese, M. M., Joyce, M. P., Ortega‐Sanchez, I. R., Lee, G. M., Tiwari, T., Cohn, A. C., Slade, B. A., Iskander, J. K., et al. (2006) · PubMed · Cited by 373
Morbidity of Pertussis in Adolescents and Adults
De Serres, G., Shadmani, R., Duval, B., Boulianne, N., Déry, P., Douville Fradet, M., Rochette, L., & Halperin, S. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315648 · Cited by 344
Self-citationCherry, J. D. (2005) · Pediatrics · doi:10.1542/peds.2004-2648 · Cited by 237
The Changing Age and Seasonal Profile of Pertussis in Canada
Skowronski, D. M., De Serres, G., MacDonald, D., Wu, W., Shaw, C., Macnabb, J., Champagne, S., Patrick, D. M., & Halperin, S. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/340280 · Cited by 231
Self-citationCombined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults
Pichichero, M. E. (2005) · JAMA · doi:10.1001/jama.293.24.3003 · Cited by 141
The Control of Pertussis — 2007 and Beyond
Halperin, S. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068288 · Cited by 125
Self-citationEdwards, K. M. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000166154.47013.47 · Cited by 119
Le Saux, N., Barrowman, N. J., Moore, D. L., Whiting, S., Scheifele, D., Halperin, S., & for Members of the Canadian Paediatric Society/ Health Canada Immunization Monitoring Program–Active (IMPACT) (2003) · Pediatrics · doi:10.1542/peds.112.5.e348 · Cited by 111
Self-citationEpidemiology of Haemophilus influenzae Serotype a, North American Arctic, 2000–2005
Bruce, M. G., Deeks, S. L., Zulz, T., Navarro, C., Palacios, C., Case, C., Hemsley, C., Hennessy, T., Corriveau, A., Larke, B., et al. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1401.070822 · Cited by 96
Issues Associated with and Recommendations for Using PCR To Detect Outbreaks of Pertussis
Lievano, F. A., Reynolds, M. A., Waring, A. L., Ackelsberg, J., Bisgard, K. M., Sanden, G. N., Güriş, D., Golaz, A., Bopp, D. J., Limberger, R. J., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.2801-2805.2002 · Cited by 96
Singleton, R. J., Hammitt, L. L., Hennessy, T., BULKOW, L. R., DeByle, C. K., Parkinson, A. J., Cottle, T. E., Peters, H. V., & Butler, J. C. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0287 · Cited by 88
Changing epidemiology and emerging risk groups for pertussis
Galanis, E., King, A. S., Varughese, P., & Halperin, S. A. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050379 · Cited by 83
Self-citationImmunization monitoring program, active: a model of active surveillance of vaccine safety
Scheifele, D. W., & Halperin, S. A. (2003) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(03)00036-0 · Cited by 81
Self-citationMcConnell, A., Tan, B., Scheifele, D. W., Halperin, S. A., Vaudry, W., LAW, B. J., & Embreé, J. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31812f4f5b · Cited by 80
Self-citationHalperin, S. A., Bortolussi, R. A., Langley, J. M., Eastwood, B. J., & Serres, G. D. (1999) · PEDIATRICS · doi:10.1542/peds.104.4.e42 · Cited by 77
Self-citationDecker, M. D. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200111001-00002 · Cited by 77
Mills, E. L., Gold, R., Thipphawong, J., Barreto, L., Guasparini, R., Meekison, W., Cunning, L., Russell, M. L., Harrison, D., Boyd, M., et al. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00241-7 · Cited by 71
Tsang, R. S. W., Sill, M. L., Skinner, S. J., Law, D. K. S., Zhou, J., & Wylie, J. (2007) · Clinical Infectious Diseases · doi:10.1086/518283 · Cited by 71
Parkinson, A. J., Bruce, M. G., Zulz, T., & the International Circumpolar Surveillance Steering Committee (2008) · Emerging Infectious Diseases · doi:10.3201/eid1401.070717 · Cited by 62
Bentsi-Enchill, A. D., Halperin, S. A., Scott, J., MacIsaac, K., & DUCLOS, P. J. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00176-4 · Cited by 59
Self-citationInvasive Haemophilus influenzae in Manitoba, Canada, in the Postvaccination Era
Tsang, R. S. W., Mubareka, S., Sill, M. L., Wylie, J., Skinner, S., & Law, D. K. S. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1530-1535.2006 · Cited by 58
Scheifele, D. W. (1996) · Europe PMC (PubMed Central) · Cited by 54
Self-citationBettinger, J. A., Halperin, S. A., Serres, G. D., Scheifele, D. W., & Tam, T. W. S. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000247055.81541.04 · Cited by 53
Self-citationLee, C., Thipphawong, J., Huang, L., Lee, P., Chiu, H., Lin, W., Debois, H., Harrison, D., Xie, F., & Barreto, L. (1999) · PEDIATRICS · doi:10.1542/peds.103.1.25 · Cited by 51
Scheifele, D. W. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031861 · Cited by 46
Self-citationSotir, M. J., Cappozzo, D. L., Warshauer, D. M., Schmidt, C. E., Monson, T. A., Berg, J. L., Zastrow, J. A., Gabor, G. W., & Davis, J. P. (2007) · Clinical Infectious Diseases · doi:10.1086/513432 · Cited by 45
Effectiveness of a whole cell pertussis vaccine in child-care centers and schools
Serres, G. D., Boulianne, N., Duval, B., Déry, P., RODRIGUEZ, A. M., Massé, R., & Halperin, S. A. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199606000-00009 · Cited by 41
Self-citationPrevention of pertussis in adolescents and adults.
(2003) · PubMed · Cited by 35
Invasive Bacterial Diseases in Northern Canada
Degani, N., Navarro, C., Deeks, S. L., Lovgren, M., & the Canadian International Circumpolar Surveillance Working Group (2008) · Emerging infectious diseases · doi:10.3201/eid1401.061522 · Cited by 34
Measuring up: results from the National Immunization Coverage Survey, 2002.
McWha, L., MacArthur, A., Badiani, T., Schouten, H., Tam, T., & King, A. (2004) · PubMed · Cited by 29
Kandola, K., Lea, A., White, W., & Santos, M. A. (2005) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2005/642315 · Cited by 27
Self-citationHaemophilus influenzae vaccine.
Jick, H., Withers, J. M., & Dean, A. D. (1995) · Europe PMC (PubMed Central) · Cited by 24
BLACK, S. B., & Greenberg, D. P. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.6.793 · Cited by 22
Self-citationMarchessault, V., Spika, J. S., Armstrong, N., Bowmer, I., Serres, G. D., Wals, P. D., Embreé, J., Gemmill, I. M., Naus, M., Orr, P., et al. (2000) · Canada Communicable Disease Report · Cited by 22
Historic low Haemophilus influenzae type B case tally--Canada 2000.
Scheifele, D. W., Halperin, S. A., Vaudry, W., Jadavji, T., Tan, B., Law, B., Saux, N. M. L., Ford-Jones, L., LEBEL, M. H., MOORE, D. L., et al. (2001) · PubMed · Cited by 20
Self-citationA Countywide Outbreak of Pertussis
Sotir, M. J., Cappozzo, D. L., Warshauer, D. M., Schmidt, C. E., Monson, T. A., Berg, J. L., Zastrow, J. A., Gabor, G. W., & Davis, J. P. (2008) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2007.7 · Cited by 19
Edwards, K. M., & Decker, M. D. (2001) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70276-2 · Cited by 18
Haemophilus influenzae type B disease control using PENTACEL, Canada, 1998-1999.
Scheifele, D. W., & Halperin, S. A. (2000) · PubMed · Cited by 12
Self-citationHalperin, S. A. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.8.807 · Cited by 8
Self-citationHaemophilus influenzae type B disease at 11 pediatric centres, 1996-1997.
Grewal, S., & Scheifele, D. W. (1998) · PubMed · Cited by 7
Self-citationPertussis in Newfoundland and Labrador: 1991-2004.
(2005) · PubMed · Cited by 4
Research works printed but not linked: 4
- 2000, Health Canada. Case definitions for diseases under national surveillance., Can Commun Dis Rep, 26, 101
- Scheifele, 1996, Recent trends in pediatric Haemophilus influenzae type b infections in Canada., Can Med Assoc J, 154, 1041
- 2005, IMPACT highlights. Invasive Haemophilus influenzae type b cases–2004., Paediatr Child Health, 10, 314
- Bettinger, 2005, Epidemiology of hospitalized pertussis after change from whole-cell to acellular pertussis vaccine. 6th Canadian Immunization Conference 2004., CCDR, 31
Cited by
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30299-5 · Cited by 2,275
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013
Tan, T., Dalby, T., Forsyth, K., Halperin, S. A., Heininger, U., Hozbor, D., Plotkin, S., Ulloa-Gutierrez, R., & Wirsing von König, C. H. (2015) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000795 · Cited by 232
Self-citationWaning Tdap Effectiveness in Adolescents
Klein, N. P., Bartlett, J., Fireman, B., & Baxter, R. (2016) · Pediatrics · doi:10.1542/peds.2015-3326 · Cited by 140
Pertussis control: time for something new?
Clark, T. A., Messonnier, N. E., & Hadler, S. C. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.03.003 · Cited by 87
Metadata
- Authors
- Greenberg, D. P., Doemland, M., Bettinger, J. A., Scheifele, D. W., Halperin, S. A., Waters, V., & Kandola, K.
- Affiliations
- Sanofi (United States) (US)
- University of British Columbia (CA)
- Dalhousie University (CA)
- Hospital for Sick Children (CA)
- Government of Northwest Territories (CA)
- Corresponding author
- Greenberg, David P.
- Doemland, Martha
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2009-06
- Volume
- 28
- Issue
- 6
- Pages
- 521-528
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2100431291
- Cited by
- 40
- References
- 51
- Citations by year
- 2023: 1 · 2020: 4 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Pediatric Infectious Disease Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- pertussis, Haemophilus influenzae type b, invasive Hib disease, DTaP-IPV-Hib vaccine, Tdap vaccine, acellular pertussis vaccine, vaccine epidemiology, herd immunity, vaccination coverage, Aboriginal children, Canada, United States
- MeSH terms
- Adolescent, Adult, Canada, Child, Child, Preschool, Inuit, Haemophilus Infections, Humans, Infant, Poliovirus Vaccine, Inactivated, Population Surveillance, United States, Whooping Cough, Diphtheria-Tetanus-Pertussis Vaccine, Vaccines, Combined, Haemophilus Vaccines, Vaccines, Conjugate, Haemophilus influenzae type b, Diphtheria-Tetanus-acellular Pertussis Vaccines, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.